Literature DB >> 22651134

Knockdown of OY-TES-1 by RNAi causes cell cycle arrest and migration decrease in bone marrow-derived mesenchymal stem cells.

Yan-Hui Cen1, Wen-Wen Guo, Bin Luo, Yong-Da Lin, Qing-Mei Zhang, Su-Fang Zhou, Guo-Rong Luo, Shao-Wen Xiao, Xiao-Xun Xie.   

Abstract

OY-TES-1 is a member of the CTA (cancer-testis antigen) group expressed in a variety of cancer and restrictedly expressed in adult normal tissues, except for testis. To determine whether MSCs (mesenchymal stem cells) express OY-TES-1 and its possible roles on MSCs, OY-TES-1 expression in MSCs isolated from human bone marrow was tested with RT (reverse transcription)-PCR, immunocytochemistry and Western blot. Using RNAi (RNA interference) technology, OY-TES-1 expression was knocked down followed by analysing cell viability, cell cycle, apoptosis and migration ability. MSCs expressed OY-TES-1 at both mRNA and protein levels. The down-regulation of OY-TES-1 expression in these MSCs caused cell growth inhibition, cell cycle arrest, apoptosis induction and migration ability attenuation. Through these primary results it was suggested that OY-TES-1 may influence the biological behaviour of MSCs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22651134     DOI: 10.1042/CBI20120037

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  6 in total

1.  FMR1NB Involved in Glioma Tumorigenesis Is a Promising Target for Prognosis and Therapy.

Authors:  Shui-Qing Bi; Ya Peng; Zong-Dang Wei; Sheng-Zhong Yao; Bin Luo; Ying-Ying Ge; Xiao-Xun Xie; Wei-Xia Nong; Chang Liu; Shao-Wen Xiao; Qing-Mei Zhang
Journal:  Curr Med Sci       Date:  2022-07-11

2.  Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters.

Authors:  Bin Luo; Xiang Yun; Rong Fan; Yong-Da Lin; Shu-Jia He; Qing-Mei Zhang; Fa-Rong Mo; Fang Chen; Shao-Wen Xiao; Xiao-Xun Xie
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

3.  Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro.

Authors:  Jun Fu; Bin Luo; Wen-Wen Guo; Qing-Mei Zhang; Lei Shi; Qi-Ping Hu; Fang Chen; Shao-Wen Xiao; Xiao-Xun Xie
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

4.  Serum immunoreactivity of cancer/testis antigen OY-TES-1 and its tissues expression in glioma.

Authors:  Xisheng Li; Jun Yan; Rong Fan; Bin Luo; Qingmei Zhang; Yongda Lin; Sufang Zhou; Guorong Luo; Xiaoxun Xie; Shaowen Xiao
Journal:  Oncol Lett       Date:  2017-03-03       Impact factor: 2.967

5.  Immunohistochemistry Study of OY-TES-1 Location in Fetal and Adult Human Tissues.

Authors:  Jun Fu; Yongda Lin; Chang Liu; Weixia Nong; Xin Luo; Shaowen Xiao; Xiaoxun Xie; Bin Luo
Journal:  J Healthc Eng       Date:  2022-04-13       Impact factor: 3.822

6.  Cancer-testis antigen ACRBP expression and serum immunoreactivity in ovarian cancer: Its association with prognosis.

Authors:  Lina Lin; Weixia Nong; Bin Luo; Yingying Ge; Xia Zeng; Feng Li; Rong Fan; Qingmei Zhang; Xiaoxun Xie
Journal:  Immun Inflamm Dis       Date:  2021-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.